Essex Bio-Technology logo

1061 - Essex Bio-Technology Share Price

HK$5.56 -0.2  -3.0%

Last Trade - 9:08am

Small Cap
Market Cap £342.8m
Enterprise Value £330.9m
Revenue £132.4m
Position in Universe 1400th / 5945
Unlock 1061 Revenue
Relative Strength (%)
1m +13.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
518.3 654 775.7 899.6 1,176 1,279 1,768 2,078 +19.8%
+37.5 +39.9 +26.8 +22.1 +34.3 +29.7 +19.3 +18.0
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2019, Essex Bio-Technology Limited revenues increased 9% to HK$1.28B. Net income increased 31% to HK$302.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Distribution and selling expenses decrease of 3% to HK$632.8M (expense), Licensing income increase from HK$0K to HK$8M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


1061 Revenue Unlock 1061 Revenue

Net Income

1061 Net Income Unlock 1061 Revenue

Normalised EPS

1061 Normalised EPS Unlock 1061 Revenue

PE Ratio Range

1061 PE Ratio Range Unlock 1061 Revenue

Dividend Yield Range

1061 Dividend Yield Range Unlock 1061 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1061 EPS Forecasts Unlock 1061 Revenue
Profile Summary

Essex Bio-Technology Limited is an investment holding company principally engaged in the manufacture and sales of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Company develops biopharmaceutical drugs based on recombinant deoxyribonucleic acid (DNA) technology. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin. The Company operates through two business segments. The Pharmaceutical Products segment is engaged in the development, manufacture and sales of pharmaceutical products. The Provision of Marketing Services segment is involved in the distribution of third party products and provision of marketing services to such third party’s products.

Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated July 31, 2000
Public Since June 27, 2001
No. of Shareholders: n/a
No. of Employees: 1,110
Sector Healthcare
Industry Pharmaceuticals
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 577,937,000
Free Float (0.0%)
Eligible for
1061 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 1061
Upcoming Events for 1061
Frequently Asked Questions for Essex Bio-Technology
What is the Essex Bio-Technology share price?

As of 9:08am, shares in Essex Bio-Technology are trading at HK$5.56, giving the company a market capitalisation of £342.8m. This share price information is delayed by 15 minutes.

How has the Essex Bio-Technology share price performed this year?

Shares in Essex Bio-Technology are currently trading at HK$5.56 and the price has moved by -15.74% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Essex Bio-Technology price has moved by -6.79% over the past year.

What are the analyst and broker recommendations for Essex Bio-Technology?

Of the analysts with advisory recommendations for Essex Bio-Technology, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Essex Bio-Technology is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Essex Bio-Technology next release its financial results?

Essex Bio-Technology is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Essex Bio-Technology dividend yield?

The Essex Bio-Technology dividend yield is 1.48% based on the trailing twelve month period.

Does Essex Bio-Technology pay a dividend?

Last year, Essex Bio-Technology paid a total dividend of 0.09, and it currently has a trailing dividend yield of 1.48%. Looking ahead, Essex Bio-Technology has not announced an ex-dividend date yet.

When does Essex Bio-Technology next pay dividends?

Essex Bio-Technology has yet to annouce their ex-dividend date. The historic dividend yield on Essex Bio-Technology shares is currently 1.48%.

How do I buy Essex Bio-Technology shares?

To buy shares in Essex Bio-Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Essex Bio-Technology?

Shares in Essex Bio-Technology are currently trading at HK$5.56, giving the company a market capitalisation of £342.8m.

Where are Essex Bio-Technology shares listed? Where are Essex Bio-Technology shares listed?

Here are the trading details for Essex Bio-Technology:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 1061
What kind of share is Essex Bio-Technology?

Based on an overall assessment of its quality, value and momentum, Essex Bio-Technology is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Essex Bio-Technology share price forecast 2020?

Shares in Essex Bio-Technology are currently priced at HK$5.56. At that level they are trading at 78.01% discount to the analyst consensus target price of 0.00.

Analysts covering Essex Bio-Technology currently have a consensus Earnings Per Share (EPS) forecast of 0.61 for the next financial year.

How can I tell whether the Essex Bio-Technology share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Essex Bio-Technology. Over the past six months, the relative strength of its shares against the market has been 1%. At the current price of HK$5.56, shares in Essex Bio-Technology are trading at 5.43% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Essex Bio-Technology PE Ratio?

The Essex Bio-Technology PE ratio based on its reported earnings over the past 12 months is 11.2. The shares are currently trading at HK$5.56.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Essex Bio-Technology?

Essex Bio-Technology's management team is headed by:

Mia Je Ngiam - CHM
Haizhou Fang - MDR
Sheng Zhong - EDR
Chi Ying Fung - NID
Benoit Mauffrey - NID
Mee Mooi Yeow - NID
Lai Man Yau - SEC
Xinzhi Wang - OTH
Who are the major shareholders of Essex Bio-Technology?

Here are the top five shareholders of Essex Bio-Technology based on the size of their shareholding:

Ngiam (Mia Je Patrick) Individual Investor
Percentage owned: 25.48% (147.3m shares)
Ngiam (Mia Kiat Benjamin) Individual Investor
Percentage owned: 25.15% (145.4m shares)
Fidelity Management & Research Company Investment Advisor
Percentage owned: 1.24% (7.16m shares)
Dynatech Ventures Pte. Ltd. Corporation
Percentage owned: 1.15% (6.67m shares)
Fang (Haizhou) Individual Investor
Percentage owned: 0.91% (5.24m shares)
Similar to 1061
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.